Meer Fakhry
Internal Medicine · Columbia, SCNPI 1558855866
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (45.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Abbott at 59.3% of the total. Among internal medicine clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $174.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$13K
- Medtronic$6K
- Boston Scientific$2K
- Biosense Webster, Inc.$421
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$306
- Cordis US CORP.$147
- plus $530 from 10 others
What the payments were for
- Grants$10,00045%
- Travel & lodging$6,64830%
- Food & beverage$4,51720%
- Education$9444%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 63 | $13,101 |
| Medtronic | 9 | $5,701 |
| Boston Scientific | 10 | $1,905 |
| Biosense Webster, Inc. | 11 | $421 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $306 |
| Cordis US CORP. | 14 | $147 |
| AstraZeneca | 4 | $144 |
| Actelion Pharmaceuticals US, Inc. | 1 | $124 |
| Abiomed | 1 | $64 |
| Johnson & Johnson | 2 | $48 |
| Impulse Dynamics (USA) Inc. | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Atricure, Inc. | 1 | $25 |
| Pfizer | 1 | $20 |
| Amgen | 1 | $19 |
| Merck | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE PRECISION$3,016
- ENSITE$2,809
- Farapulse$1,503
- Micra$401
- HeartMate 3 Left Ventricular Assist Device$207
- WATCHMAN FLX$143
- Carto 3$142
- GALLANT$142
- AVEIR$128
- UPTRAVI$124
- OPSUMIT$124
- LifeVest$103
How this compares
$22,110 in reported general payments places this provider in the 95th percentile of 1,498 internal medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $8,400 |
| Amiodarone Hcl | 13 | $201 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $20 | $8,40013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,498 internal medicine providers in South Carolina.
Other internal medicine in Columbia
- Laura LabooneColumbia$16K
- Charles ButlerColumbia$15K
- Adelero AdebajoColumbia$12K
- Robert CollinsColumbia$11K
- Albert HumphreyColumbia$10K
- Elizabeth LebelColumbia$10K
- Jerry BackNorth Charleston$322K
- Jan BasileCharleston$278K
- Mark PurcellGreenville$165K
- John CleekCharleston$136K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.